The pharmacological treatment of bradycardia and atrioventricular conduction disturbances during STEMI is a therapeutic, not prophylactic, measure. Pharmacotherapy centers on the use of atropine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback